KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Change in Inventory: 2020-2024

Historic Change in Inventory for Esperion Therapeutics (ESPR) over the last 5 years, with Dec 2024 value amounting to $28.9 million.

  • Esperion Therapeutics' Change in Inventory fell 35.72% to -$5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.4 million, marking a year-over-year decrease of 0.80%. This contributed to the annual value of $28.9 million for FY2024, which is 5.11% down from last year.
  • Esperion Therapeutics' Change in Inventory amounted to $28.9 million in FY2024, which was down 5.11% from $30.4 million recorded in FY2023.
  • In the past 5 years, Esperion Therapeutics' Change in Inventory registered a high of $30.4 million during FY2023, and its lowest value of $807,000 during FY2022.
  • In the last 3 years, Esperion Therapeutics' Change in Inventory had a median value of $28.9 million in 2024 and averaged $20.0 million.
  • As far as peak fluctuations go, Esperion Therapeutics' Change in Inventory plummeted by 95.58% in 2022, and later soared by 3,669.76% in 2023.
  • Yearly analysis of 5 years shows Esperion Therapeutics' Change in Inventory stood at $16.1 million in 2020, then climbed by 13.15% to $18.3 million in 2021, then slumped by 95.58% to $807,000 in 2022, then skyrocketed by 3,669.76% to $30.4 million in 2023, then dropped by 5.11% to $28.9 million in 2024.